Aandeel DYNS DYNC SPL
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen DYNC SPL

Aandelen

DYNS

US2680101050

Beurs gesloten - Nasdaq
Andere beurzen
 22:00:00 02-07-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,39 USD -6,59% Intraday-grafiek van DYNC SPL -95,78% -94,81%
2022 Senti Biosciences voltooit bedrijfscombinatie, zal donderdag beginnen te handelen op Nasdaq MT
2022 Senti Biosciences, Inc. heeft de overname van Dynamics Special Purpose Corp. (NasdaqCM:DYNS) van een groep aandeelhouders in een omgekeerde-fusietransactie voltooid. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
DYNC SPL : SENTI BIOSCIENCES, INC. INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
Senti Biosciences Completes Business Combination, Will Begin Trading on Nasdaq Thursday
DYNC SPL : Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits - Form 8-K
DYNAMICS SPECIAL PURPOSE CORP. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits
Dynamics Special Purpose Corp.(NasdaqCM:DYNS) dropped from NASDAQ Composite Index
Senti Biosciences, Inc. completed the acquisition of Dynamics Special Purpose Corp. from a group of shareholders in a reverse merger transaction.
DYNAMICS SPECIAL PURPOSE CORP. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
Dynamics Special Purpose Corp. has Changed its Name to Senti Biosciences, Inc
Dynamics Special Purpose Corp. Approves Board Elections
Dynamics Special Purpose : Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer - Form 8-K
DYNAMICS SPECIAL PURPOSE CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effectiveness of registration statement on Form S-4 - - Meeting of DYNS stockholders to approve proposed business combination scheduled for Tuesday, June 7, 2022 at 10:00 a.m. ET - Form 8-K
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
DYNAMICS SPECIAL PURPOSE CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Dynamics Special Purpose Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
SPACs splash the cash to salvage deals as market unravels
DYNAMICS SPECIAL PURPOSE CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Dynamics Special Purpose Corp. Reports Earnings Results for the Ten Months Ended December 31, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers DYNS
  4. Nieuws DYNC SPL
  5. Andere talen